111 related articles for article (PubMed ID: 19945313)
1. Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells.
Perabo FG; Landwehrs G; Frössler C; Schmidt DH; Mueller SC
Urol Oncol; 2011; 29(6):815-20. PubMed ID: 19945313
[TBL] [Abstract][Full Text] [Related]
2. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
[TBL] [Abstract][Full Text] [Related]
3. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells.
Kameswaran TR; Ramanibai R
Biomed Pharmacother; 2009 Feb; 63(2):146-54. PubMed ID: 18450412
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by a novel indirubin-5-nitro-3'-monoxime, a CDK inhibitor, in human lung cancer cells.
Lee JW; Moon MJ; Min HY; Chung HJ; Park EJ; Park HJ; Hong JY; Kim YC; Lee SK
Bioorg Med Chem Lett; 2005 Sep; 15(17):3948-52. PubMed ID: 15993584
[TBL] [Abstract][Full Text] [Related]
5. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
Shi J; Shen HM
Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873
[TBL] [Abstract][Full Text] [Related]
6. Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.
Zhen Y; Sørensen V; Jin Y; Suo Z; Wiedłocha A
Oncogene; 2007 Sep; 26(44):6372-85. PubMed ID: 17533378
[TBL] [Abstract][Full Text] [Related]
7. Effect of indirubin-3-monoxime against lung cancer as evaluated by histological and transmission electron microscopic studies.
Ravichandran K; Pal A; Ravichandran R
Microsc Res Tech; 2010 Oct; 73(11):1053-8. PubMed ID: 20169620
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells.
Marko D; Schätzle S; Friedel A; Genzlinger A; Zankl H; Meijer L; Eisenbrand G
Br J Cancer; 2001 Jan; 84(2):283-9. PubMed ID: 11161389
[TBL] [Abstract][Full Text] [Related]
10. Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.
Damiens E; Baratte B; Marie D; Eisenbrand G; Meijer L
Oncogene; 2001 Jun; 20(29):3786-97. PubMed ID: 11439342
[TBL] [Abstract][Full Text] [Related]
11. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
York M; Abdelrahim M; Chintharlapalli S; Lucero SD; Safe S
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6743-52. PubMed ID: 18006776
[TBL] [Abstract][Full Text] [Related]
12. An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin.
Lo WY; Chang NW
PLoS One; 2013; 8(8):e70198. PubMed ID: 23967071
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
Schwartz MJ; Liu H; Hwang DH; Kawamoto H; Scherr DS
Urology; 2009 May; 73(5):1156-62. PubMed ID: 19118885
[TBL] [Abstract][Full Text] [Related]
14. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
[TBL] [Abstract][Full Text] [Related]
15. Cafestol, a coffee-specific diterpene, induces apoptosis in renal carcinoma Caki cells through down-regulation of anti-apoptotic proteins and Akt phosphorylation.
Choi MJ; Park EJ; Oh JH; Min KJ; Yang ES; Kim YH; Lee TJ; Kim SH; Choi YH; Park JW; Kwon TK
Chem Biol Interact; 2011 Apr; 190(2-3):102-8. PubMed ID: 21334318
[TBL] [Abstract][Full Text] [Related]
16. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
[TBL] [Abstract][Full Text] [Related]
17. Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling.
Lee MJ; Kim MY; Mo JS; Ann EJ; Seo MS; Hong JA; Kim YC; Park HS
Cancer Lett; 2008 Jul; 265(2):215-25. PubMed ID: 18343569
[TBL] [Abstract][Full Text] [Related]
18. Indirubin-3'-monoxime inhibits beta-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells.
Zhang S; Zhang Y; Xu L; Lin X; Lu J; Di Q; Shi J; Xu J
Neurosci Lett; 2009 Jan; 450(2):142-6. PubMed ID: 19027827
[TBL] [Abstract][Full Text] [Related]
19. 6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.
Xingi E; Smirlis D; Myrianthopoulos V; Magiatis P; Grant KM; Meijer L; Mikros E; Skaltsounis AL; Soteriadou K
Int J Parasitol; 2009 Oct; 39(12):1289-303. PubMed ID: 19445946
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
